Skip to content

BCTXZ BRIACELL THERAPEUTICS CORP

Follow

*W EXP 99/99/999 (warrant or right), issuer CIK 1610820

Filings received so far for Q3 2026: 4 13F filers report a position in BCTXZ shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
HEIGHTS CAPITAL MANAGEMENT, INCin group HEIGHTS CAPITAL MANAGEMENT, I…296,089$58.6K0.01%-17,29013F-HRTimelineGroup
SUSQUEHANNA INTERNATIONAL GROUP, LLPin group SUSQUEHANNA INTERNATIONAL GRO…287,547$56.9K<0.01%+173,02513F-HRTimelineGroup
HRT FINANCIAL LP164,379$32K<0.01%+96,44413F-HRTimeline
UBS Group AGin group UBS Group AG3,828$758<0.01%new13F-HRTimelineGroup